Banu K Arun, MD
Disclosures: Nothing to disclose - 01/19/2021

Dr.Banu Arun is tenured Professor in Department of Breast Medical Oncology, Co-Medical Director of the Clinical Cancer Genetics Program and Section Chief Breast Genetics, Prevention and Screening at the University of Texas MD Anderson Cancer Center. She also serves as Executive Director Cancer Genetics for MD Anderson Networks. Her research focuses on identifying risk biomarkers for breast cancer and prevention, and characterizing risk factors in a cohort of high-risk women with hereditary gene mutations (BRCA and others) as well as assessing breast cancer biology in these patients. She has served as the Principal Investigator on several clinical trials evaluating agents such as letrozole, imatinib, gemcitabine, R115777 and PARP inhibitors for metastatic breast cancer (including BRCA positive,) and celecoxib, atorvastatin and dasatinib and tamoxifen gel in short-term breast cancer prevention trials. Her research also include outreach and education, as well as cascade genetic testing of family members.

Given her national and international expertise she has served in several committees, including The American Society of Clinical Oncology (ASCO) Prevention committee and currently serves as the Co-Chair for the Southwest Oncology Group (SWOG) Prevention and Epidemiology Committee and member of the NCCN Breast Cancer Risk Reduction Guideline Committee, member of the ASCO BOLD task force, member of ASCO Prevention Education committee, and member of the National Cancer Institute (NCI) Cancer Prevention Steering Committee. She served as grant reviewer for Susan Komen and NCI P01 and reviewed for journals including JCO, Cancer, BMJ, Cancer Prevention and Epidemiology, amongst others. She has more than 200 peer reviewed publications and received research grants from the NCI, Susan Komen Foundation, DOD and CPRIT.

Dr.Arun was featured in Forbes (December 2017) as one of the top 30 Breast Medical Oncologists in the United States. She has received FASCO award recognition in 2020 from the American Society of Clinical Oncology. Dr.Arun is also the recipient of the ASCO-American Cancer Society 2021 Award.